1011.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 08:14):

Stats
Dagens volum	3.67M
Gjennomsnittsvolum	7.67M
Markedsverdi	71.30M
EPS	HKD0 ( 2023-08-31 )
Last Dividend	HKD0.0350 ( 2018-07-10 )
Next Dividend	HKD0 ( N/A )
P/E	-1.350
ATR14	HKD0.00100 (3.70%)

China NT Pharma Group Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

China NT Pharma Group Økonomi

Annual	2023
Omsetning:	HKD7.37M
Bruttogevinst:	HKD7.37M (100.00 %)
EPS:	HKD-0.0169

FY	2023
Omsetning:	HKD7.37M
Bruttogevinst:	HKD7.37M (100.00 %)
EPS:	HKD-0.0169

FY	2022
Omsetning:	HKD207.09M
Bruttogevinst:	HKD125.29M (60.50 %)
EPS:	HKD-0.0350

FY	2021
Omsetning:	HKD226.70M
Bruttogevinst:	HKD145.46M (64.16 %)
EPS:	HKD-0.0792

Financial Reports:

No articles found.

China NT Pharma Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China NT Pharma Group Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 2.59 - low (50.00%) | Divividend Growth Potential Score: 2.40 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0100	2016-05-31
Last Dividend	HKD0.0350	2018-07-10
Next Dividend	HKD0	N/A
Payout Date	2018-08-02
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.0700	--
Avg. Dividend % Per Year	0.00%	--
Score	1.28	--
Div. Sustainability Score	2.59
Div.Growth Potential Score	2.40
Div. Directional Score	2.50	--

Next Divdend (Est)
(2025-01-27)

HKD0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

1.28

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
87001.HK	Ex Dividend Junior	2023-08-10	Semi-Annually	0.00%
2107.HK	Ex Dividend Junior	2023-06-29	Annually	0.00%
1114.HK	Ex Dividend Junior	2023-08-11	Annually	0.00%
0189.HK	Ex Dividend Junior	2023-06-14	Annually	0.00%
3808.HK	Ex Dividend Junior	2023-07-04	Annually	0.00%
1696.HK	Ex Dividend Junior	2023-08-24	Annually	0.00%
0730.HK	Ex Dividend Junior	2023-05-24	Annually	0.00%
2283.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
1270.HK	Ex Dividend Knight	2023-05-16	Annually	0.00%
0323.HK	No Dividend Player	2023-06-21	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.259	1.500	-5.17	-7.76	[0 - 0.5]
returnOnAssetsTTM	-0.133	1.200	-4.43	-5.32	[0 - 0.3]
returnOnEquityTTM	0.149	1.500	9.45	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.0185	0.800	-4.91	-3.93	[1 - 3]
quickRatioTTM	0.0174	0.800	-4.60	-3.68	[0.8 - 2.5]
cashRatioTTM	0.00229	1.500	-1.098	-1.648	[0.2 - 2]
debtRatioTTM	1.046	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.00526	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00439	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	-1.014	-1.500	-4.06	6.08	[0 - 2.5]
grossProfitMarginTTM	0.607	1.000	3.22	3.22	[0.2 - 0.8]
operatingProfitMarginTTM	0.215	1.000	7.70	7.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0343	1.000	-0.921	-0.921	[0.2 - 2]
assetTurnoverTTM	0.514	0.800	9.91	7.92	[0.5 - 2]
Total Score				2.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.233	1.000	-0.226	0	[1 - 100]
returnOnEquityTTM	0.149	2.50	9.65	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00439	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00526	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0697	1.000	-0.757	0	[0.1 - 0.5]
Total Score				2.40

China NT Pharma Group

China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.